IDEX Corporation research snapshot
IEX AI stock analysis currently reads IDEX Corporation as a high-quality industrial compounder with accelerating demand in data center, semiconductor, and space and defense applications, strong cash conversion, disciplined capital allocation, and a raised 2026 outlook. At the August 2, 2026 data cutoff, IEX traded near $230.45 with a verified market capitalization near $16.99 billion. The IEX AI stock forecast uses scenario ranges rather than a fixed price prediction because HST order momentum, segment mix, acquisition integration, industrial demand, tariffs, rates, and the market multiple can all change the outcome.
Current price
$230.45 close on July 31, 2026
Market cap
$16.99 billion verified market cap
AI score
74 / 100
Rating
High-quality engineered products compounder with accelerating HST orders, raised 2026 guidance, and a valuation that already prices in strong growth
Trend status
Above the 50-day and 200-day moving averages with constructive momentum near the 52-week high
Data cutoff (updated monthly)
August 4, 2026
Informational use only. This page is not investment advice.
| Dimension | Conclusion | Confidence |
|---|---|---|
| Business quality | IDEX sells mission-critical precision components, fluidics, pumps, sealing, fire and safety products, and dispensing systems into specialized markets. The business has attractive cash conversion, rising operating margins, and niche-market economics. | High |
| Moat | The moat comes from application know-how, customer qualification, brand portfolios, installed bases, specialized engineering, distribution reach, and scale in selected niches rather than a broad network effect. | Medium-high |
| Management | CEO Eric D. Ashleman and CFO Sean Gillen are executing on HST growth platforms, 80/20 simplification, portfolio management, share repurchases near $77 million per quarter, and a modest CapEx lift to support 2027 demand. | Medium-high |
| Financial trend | Q2 2026 revenue was $920.6 million, up 6.38% year over year. Organic sales rose 5%, orders rose 28% organically, adjusted EPS rose 12% to $2.32, and management raised 2026 adjusted EPS guidance to $8.70 to $8.85. | High |
| Valuation | At $230.45, the financial-rigor tool calculates about 33.16x TTM EPS, 4.25x book value, 26.49x free cash flow per share, and a 1.27% dividend yield. The forward multiple near 25x requires durable growth and margin discipline. | High |
| Technical trend | StockAnalysis showed IEX above its 50-day moving average near $220.49 and 200-day moving average near $197.70, with RSI near 60.72, 20-day average volume near 757,807 shares, and a 52-week gain near 40.28%. | Medium |
| Risk level | Main risks include a premium valuation, industrial cycle exposure, order-to-revenue conversion timing, acquisition integration, tariffs and IEEPA refund mechanics, price-cost pressure, customer project timing, and a more expensive capital market backdrop. | Medium |
| AI confidence | Descriptive confidence is high because company releases, the Q2 2026 earnings call, SEC filings, StockAnalysis, and market data agree on the core numbers. Return confidence is lower because a premium multiple leaves less room for execution misses. | High data confidence |
| Investment certainty | IEX may fit quality-growth watchlists, but stronger certainty needs either a better entry price or evidence that HST order strength, raised guidance, and 2026 margin expansion can keep validating the current multiple. | Medium |
IEX AI stock forecast
The IEX AI stock forecast is scenario-based because the stock depends on HST order conversion, data center and semiconductor demand, segment mix, acquisitions, industrial demand, free cash flow, and the valuation multiple. Using a $230.45 price reference, the raised 2026 adjusted EPS midpoint near $8.78, and a three-year financial-rigor model, the mechanical outcomes are about $370 in a bullish case, $287 in a base case, and $186 in a bearish case before dividends.
$360 to $380 before dividends
More likely if HST order growth converts into 2026 and 2027 revenue, data center, semiconductor, and space and defense demand stays firm, adjusted EPS compounds near 12% annually, and investors keep IEX near a 30x forward multiple.
$280 to $295 before dividends
More likely if adjusted EPS compounds near 8% annually from the 2026 midpoint, HST stays strong while FMT and FSDP improve modestly, free cash flow remains high, and the market values IEX near 26x earnings.
$180 to $195 before dividends
More likely if industrial demand softens, HST order growth fades or conversion slows, acquisitions dilute returns, tariff or price-cost pressure hits margins, and the earnings multiple compresses toward 20x.
IEX AI technical analysis
IEX AI technical analysis is constructive as of the August 2, 2026 data cutoff. StockAnalysis showed a July 31 close near $230.45. Barchart listed a 5-day moving average near $228.44, a 20-day moving average near $224.04, a 50-day moving average near $220.49, a 100-day moving average near $210.77, and a 200-day moving average near $197.70, with 14-day RSI near 60.72, a 52-week high near $243.80, and 20-day average volume near 774,540 shares.
| Level | Value | Why it matters |
|---|---|---|
| Current price reference | $230.45 close | StockAnalysis showed IEX at $230.45 at the July 31, 2026 close, used for this static page and the financial-rigor market-cap calculation. |
| Immediate support | $224 to $228 | This zone brackets the 5-day moving average near $228.44 and the 20-day moving average near $224.04, the first areas where a pullback would test short-term trend support. |
| Trend support | $218 to $222 | The 50-day moving average near $220.49 sits here. Holding this zone would keep the short and medium-term uptrend intact. |
| Secondary support | $208 to $213 | The 100-day moving average near $210.77 is the next downside reference if the 50-day area fails. |
| Deeper support | $195 to $200 | This zone sits near the 200-day moving average near $197.70. A sustained break would weaken the medium-term technical picture. |
| Near resistance | $234 to $238 | This range is the first area to watch after the July 31 close and should be confirmed by volume and order-to-sales conversion. |
| Upper resistance | $243.80 to $248 | The 52-week high near $243.80 and the average analyst target near $248.43 define the upper band where valuation discipline matters most. |
| Moving averages | 5-day $228.44, 20-day $224.04, 50-day $220.49, 100-day $210.77, 200-day $197.70 | Price is above all five averages, so the trend is positive, but the distance above the 200-day average means entry timing matters. |
| Momentum | 14-day RSI near 60.72 | Momentum is constructive but not overbought. A push above the 52-week high needs price confirmation and improving volume. |
| Volume | 20-day average near 774,540 shares | Volume should be watched around Q3 results, guidance updates, acquisition news, and order commentary. |
| Volatility | 14-day historic volatility near 19.95% | Barchart reported 14-day historic volatility near 19.95% and a 14-day ATR near $6.04, so position sizing should account for larger swings around earnings and tariff news. |
| Invalidation | Close below $220, then below $197 | A close below the 50-day moving average near $220 would reduce short-term confidence. A break below the 200-day average near $197 would challenge the medium-term trend. |
IEX AI trading strategy
The IEX AI trading strategy below is a rules-based research framework, not personal advice. It connects price levels with HST order conversion, raised guidance, segment mix, free cash flow, acquisition returns, tariffs, and valuation discipline.
Watch for IEX to hold the $224 to $228 zone and then reclaim $234 to $238 with improving volume, stable or raised 2026 guidance, and continued HST order strength toward the $243.80 52-week high.
A failed breakout followed by a close below the 50-day moving average near $220 should reduce trend confidence, especially if orders or margin commentary weaken.
If IEX pulls back toward $208 to $213 without an earnings reset, compare the lower price with the $8.70 to $8.85 adjusted EPS guide, free cash flow conversion, HST order momentum, and the acquisition pipeline.
Do not treat quality as enough protection if the multiple remains high while HST order growth slows or price-cost pressure worsens.
Track HST organic orders, data center and semiconductor demand, FMT and FSDP volume trends, adjusted EBITDA margin, free cash flow, net debt, share repurchases, dividend growth, tariffs and IEEPA refunds, and M&A integration updates.
Position sizing should reflect that a strong business can still produce weak stock returns if purchased at too high a multiple.
Investment research summary
Customers pay IDEX for specialized components and systems that solve mission-critical fluidics, pumping, sealing, filtration, fire and safety, dispensing, and precision engineering problems. The value proposition is reliability in applications where downtime, contamination, failure, or inaccurate flow control can be costly.
IDEX benefits from engineering know-how, customer qualification, niche leadership, installed products, distribution, brand portfolios, and an 80/20 operating model. The moat is strong in selected applications but must be renewed through product innovation and disciplined acquisitions.
The thesis fails if investors overpay for HST momentum, data center or semiconductor demand fades, order growth does not convert to revenue, FMT and FSDP remain weak, acquisitions destroy value, or tariffs and price-cost pressure reduce margins.
Eric D. Ashleman and the leadership team frame IDEX around focused growth platforms, 80/20 simplification, portfolio upgrades, M&A, dividends, and buybacks. Capital allocation quality is central because acquired growth and record orders are part of the compounding model.
Data center power and cooling, semiconductor filtration, space and defense, municipal water, mining, and industrial automation can support long-term demand. The offset is that many end markets remain cyclical and project-driven.
IEX has quality characteristics and visible HST momentum, but the current price implies high confidence in continued growth. Margin of safety is limited unless earnings compound, free cash flow conversion stays high, and the market keeps a premium industrial multiple.
Source-backed data
Every metric below includes a source and last verification date.
| Metric | Value | Source | Last verified |
|---|---|---|---|
| Current price | $230.45 close on July 31, 2026 | StockAnalysis IEX quote page | August 1, 2026 |
| Market capitalization | $16.99 billion verified from $230.45 price and 73.72 million shares | StockAnalysis IEX quote page and financial-rigor market-cap check | August 2, 2026 |
| Shares outstanding | 73.72 million current shares, down 1.58% year over year | StockAnalysis IEX statistics | August 2, 2026 |
| Q2 2026 results | Revenue $920.6 million, up 6.38% year over year; GAAP diluted EPS $1.93; adjusted EPS $2.32 including a $0.08 IEEPA refund benefit | StockAnalysis IEX quarterly income statement and IDEX Q2 2026 earnings call | August 2, 2026 |
| Q2 2026 organic growth and orders | Organic sales +5% with HST +12%, FMT +1%, FSDP -1%; organic orders +28% with HST +47%, FMT +11%, FSDP +19% | IDEX Q2 2026 earnings call | July 29, 2026 |
| Q2 2026 margins | Adjusted gross margin 46.4%, up 110 basis points; adjusted EBITDA margin 28.1%, up 70 basis points; HST adjusted EBITDA margin up 270 basis points | IDEX Q2 2026 earnings call | July 29, 2026 |
| Raised FY2026 guidance | Organic growth 5% to 6%, up from 3% to 4%; adjusted EBITDA margin 27% to 27.3%, up from 26.5% to 27%; adjusted diluted EPS $8.70 to $8.85, up from $8.35 to $8.55 | IDEX Q2 2026 earnings call | July 29, 2026 |
| Q3 2026 guidance | Organic growth 5% to 7%, adjusted EBITDA margin 27% to 27.5%, adjusted EPS $2.20 to $2.25 | IDEX Q2 2026 earnings call | July 29, 2026 |
| FY2025 revenue and net income | Revenue $3.458 billion, up 5.77%; net income $483.2 million; EPS $6.41 | StockAnalysis IEX income statement | August 2, 2026 |
| TTM financials | Revenue $3.585 billion, gross profit $1.603 billion, operating income $741.7 million, net income $519.5 million, diluted EPS $6.95 | StockAnalysis IEX statistics and income statement | August 2, 2026 |
| Cash and debt | $621.3 million cash and $1.859 billion total debt at June 30, 2026, for net debt near $1.238 billion | StockAnalysis IEX balance sheet | August 2, 2026 |
| Free cash flow | $641.5 million TTM free cash flow, or $8.70 per share; $177 million generated in Q2 2026 | StockAnalysis IEX cash flow statement | August 2, 2026 |
| Segment revenue | TTM segment revenue: HST $1,602 million, FMT $1,241 million, FSDP $747.7 million | StockAnalysis IEX KPIs | August 2, 2026 |
| Capital returns | $77 million share repurchases and $54 million dividends in Q2 2026, with a plan to maintain about $75 million in quarterly repurchases | IDEX Q2 2026 earnings call | July 29, 2026 |
| Valuation metrics | 33.15x TTM EPS, 25.24x forward EPS, 4.25x book value, 26.48x free cash flow, 1.27% dividend yield, EV/EBITDA 19.13 | StockAnalysis IEX statistics and financial-rigor valuation check | August 2, 2026 |
| Technical reference data | 5-day moving average $228.44, 20-day moving average $224.04, 50-day moving average $220.49, 100-day moving average $210.77, 200-day moving average $197.70, 14-day RSI 60.72 | Barchart IEX technical analysis and StockAnalysis IEX statistics | July 31, 2026 |
| 52-week range and change | 52-week range $157.25 to $243.80, with a 52-week price gain near 40.28% | StockAnalysis IEX statistics | August 2, 2026 |
| Short interest | 2.36 million shares short, 3.20% of shares outstanding, about 3.34 days to cover | StockAnalysis IEX statistics | August 2, 2026 |
| Analyst consensus | Buy with an average target of $248.43 across 15 analysts, low $210, median $250.50, high $280 | StockAnalysis IEX forecast | July 30, 2026 |
| Recent analyst target updates | RBC Capital $261 to $280, Baird $257 to $274, Oppenheimer $260 to $265, Stifel $257 to $268, TD Cowen $260 to $275, Citi $252 to $269 after Q2 results | StockAnalysis IEX forecast and TipRanks | July 30, 2026 |
| 2026 and 2027 consensus estimates | FY2026 revenue estimate $3.63 billion with adjusted EPS $8.50, FY2027 revenue $3.80 billion with adjusted EPS $9.25 | StockAnalysis IEX forecast | July 30, 2026 |
| Dividend | Annual dividend $2.92 per share with a 1.27% yield, ex-dividend date July 6, 2026, and 16 years of dividend growth | StockAnalysis IEX dividend history | August 2, 2026 |
This IEX AI stock analysis is an informational research tool, not investment advice, a recommendation, or a promise of future performance. Forecast scenarios are based on available data as of August 2, 2026 and may be wrong if HST order conversion, margins, acquisitions, industrial demand, tariffs, rates, valuation multiples, or market conditions change.
Design trading strategies visually with 10+ indicators. Set entry/exit conditions and risk management, then generate Pine Script code with no coding required.
Filter and discover stocks based on market cap, dividend yield, P/E ratio, sector, and more. Screen thousands of stocks with real-time data.
Smart AI-driven stock selection with fundamental screening, analyst estimates, and key metrics. Filter by P/E, market cap, dividends, and more.
